0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Please Wait... Processing your request... Please Wait.

Not a subscriber yet?

Published monthly, JAMA Neurology brings you an international perspective on a wide range of topics from the leading centers of neurological research. Subscribe/Learn More

In the Media
Outcomes After Carotid Artery Stenting in Medicare Beneficiaries, 2005 to 2009. Jalbert et al.

Coverage by:
U.S. News & World Report
DailyRx
MedPage Today
Monthly Prescribing Reference

High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS). Nash et al.

Coverage by:
CBS News
U.S. News & World Report
Medscape
Monthly Prescribing Reference
DailyRx

Read more media coverage here.

JAMA Neurology Tweets



Follow us on Twitter

Connect with us on Google+

Current Highlights

Follow Us

Genetic Variants and Risk for Neurodegenerative Disease

This genotyping study reports that low-frequency coding variants with intermediate effect size may influence genetic susceptibility to Alzheimer disease and frontotemporal dementia.
Editorial

Cognitive Decline in Individuals With Alzheimer Disease Risk

This cohort study characterizes changes in Cognitive Function Instrument measures with cognitive changes in initially healthy older adults.

Repetitive Transcranial Magnetic Stimulation in PD

The meta-analysis summarizes effects of repetitive transcranial magnetic stimulation on motor symptoms for patients with Parkinson disease, and factors that potentially modulate the effects.

Primary Familial Brain Calcification

This systematic review summarizes clinical and neuroimaging findings in patients with genetically confirmed primary familial brain calcification, and known pathophysiological mechanisms.

GluN3A in Huntington Disease

This perspective discusses the possible role of glutamate-type N-methyl-d-aspartate receptors (NMDARs) that contain GluN3A subunits in the pathogenesis of Huntington disease, and implications for drug development.

Explore more articles:  Current Issue | Online First

Multimedia >

Author Interview

Author photo

Interview with Soko Setoguchi, MD, DrPH, author of Outcomes After Carotid Artery Stenting in Medicare Beneficiaries, 2005 to 2009, and Mark J. Alberts, MD, author of Carotid Stenting—Why Treating an Artery May Not Treat the Patient

RELATED ARTICLE:

Outcomes After Carotid Artery Stenting in Medicare Beneficiaries, 2005 to 2009

All Author Interviews >

Article Video

Video thumbnail

Meningeal Macrophage and Microglial Dynamics in the Uninjured Brain (01:22)

Representative time lapses of naive meningeal macrophages and microglia (green) captured by 2-photon microscopy through a surgically thinned skull in a CX3CR1gfp/+ mouse.


All Article Videos >

Interactive

Interactive preview


All Interactive >

Author Readings
Author photo

RELATED ARTICLE:


Latest Quiz

All Quizzes >

What is your diagnosis?

A 48-year-old woman was brought to the local hospital emergency department because of a month-long history of increasing depression, insomnia, anorexia, and weight loss and a 2-week lack of speech communication.

What is your diagnosis?

American Neurological Association Satellite Symposium

The American Neurological Association is having a satellite symposium “Circuits and Circuit Disorders: Approaches to Neuromodulation,” Saturday, September 26, 2015, 7:00 pm, Marriott Downtown Hotel, Chicago, Illinois, the evening before the start of the annual meeting. It is cosponsored by the Annals of Neurology and JAMA Neurology and features Mahlon Delong, MD, Emory University, 2014 Lasker Prize in Medicine recipient for his research in developing deep brain stimulation; Philip Starr, MD, PhD, University of California, San Francisco, the dystonias; Jonathan Mink, MD, PhD, University of Rochester Medical Center, Tourette syndrome; Helen Mayberg, MD, Emory University, depression; and Bryan L. Roth, PhD, University of North Carolina, chemogenetics.

Registration for the meeting and hotel accommodations can be obtained at http://myana.org/events/ana-2015-annual-meeting.

Call for Papers

We are asking for papers to be submitted on the subject of Neuromodulation to appear in a theme issue on Neuromodulation to be published at the time of the American Neurological Association Satellite Symposium on “Circuits and Circuit Disorders: Approaches to Neuromodulation” on September 26, 2015, cosponsored by the Annals of Neurology and JAMA Neurology, at the 140th Annual Meeting of the American Neurological Association in Chicago, Illinois, at the Marriott Downtown Hotel. Articles on deep brain stimulation related to movement disorders, Tourette syndrome, obsessive-compulsive disease, depression, chemogenetics, and related disorders will be considered.

Articles must be received by May 1, 2015, to allow time for peer review and necessary revisions, so that they may appear online in JAMA Neurology in September.

Annual Meeting: American Neurological Association

Announcing the American Neurological Association’s 140th annual meeting, Chicago, Illinois, September 27-29, 2015.

Annual Meeting: American Academy of Neurology

Announcing the American Academy of Neurology annual meeting, Washington, DC, April 18-25, 2015.

Image of JAMA forum logo

Physician Jobs